Ferrous ascorbate

DB14490ApprovedWithdrawnSmall molecule

Ferrous ascorbate is a medication used to treat iron-deficiency anemia.

Chemical structure of Ferrous ascorbate
Mechanism
Curator reviewed
Primary indication
Used in preventing and treating iron-deficiency anemia.Curator reviewed
Formula / weight
C12H14FeO12 · 406.077 g/mol (avg)
First approval
Canada, 1974
Also known as
Ferrous cevitamate · Iron(2+) L-ascorbate

Resolves to

Compound
UNIIDI3477D0PICAS24808-52-4PubChem54710214
Clinical / RWD
RxNorm4356ATCB03AA10
Structure
InChIKeyRFBYLSCVRUTUSB-ZZMNMWMASA-LSMILES[Fe++].[H][C@](O)(CO)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@](O)(CO)[C@@]1([H])OC(=O)C([O-])=C1[O-]
Targets
P02786TFRCQ9GZT9EGLN1Q9BY41HDAC8Q9NZD4AHSPP69905HBA1Q16595FXNP02794FTH1P39748FEN1+5 more

What you can answer from here — as of April 02, 2025

13Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
29Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Marketed productsAcross 2 countries and 3 labellers
Sign in
1ATC codeIncluding every combination product, plus 18 drug categories
Sign in
13+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ferrous ascorbate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In